Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of concept

Vaccine

Volumn 28, Issue 3, 2010, Pages 594-596

  Erdman, M M ^a   Kamrud, K I ^b   Harris, D L ^a   Smith, J ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b AlphaVax Inc   (United States)

Author keywords

Alphavirus; Antibodies; Hemagglutinin; Human; Influenza; Replicon particle; Swine; VEEV; Virus

Indexed keywords

ALPHAVIRUS REPLICON PARTICLE VACCINE; INFLUENZA VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ALPHA VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENCEPHALITIS VIRUS; INFLUENZA; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; REPLICON; SWINE; VENEZEULAN EQUINE ENCEPHALITIS VIRUS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; SWINE;

EID: 71149086213     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.015     Document Type: Article

References (24)

1. Hubby B., Talarico T., Maughan M., Reap E.A., Berglund P., Kamrud K.I., et al. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 25 September (2007) 8180-8189
2. Rayner J.O., Dryga S.A., and Kamrud K.I. Alphavirus vectors and vaccinations. Rev Med Virol 12 (2002) 279-296
3. Chang C.-Y., Huang C.-C., Huang T.-S., Deng M.-C., Jong M.-H., and Wang F.-I. Isolation and characterization of a Sagiyama virus from domestic pigs. J Vet Diagn Invest 18 (2006) 156-161
4. Dickerman R.W., Baker G.J., Ordonez J.V., and Cherer W.F. Venezuelan equine encephalomyelitis viremia and antibody responses of pigs and cattle. Am J Vet Res 34 March (1973) 357-361
5. Smart D.L., Trainer D.O., and Yuill T.M. Serologic evidence of Venezuelan equine encephalitis in some wild and domestic populations of southern Texas. J Wildl Dis 11 April (1975) 195-200
6. Schultz-Cherry S., Dybing J.K., Davis N.L., Williamson C., Suarez D.L., Johnston R., et al. Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278 September (2000) 55-59
7. Vincent A.L., Ma W., Lager K.M., Janke B.H., and Richt J.A. Swine influenza viruses: a North American perspective. In: Maramorosch K., Shatkin A.J., and Murphy F.A. (Eds). Advances in virus research (2008), Academic Press, Burlington 127-154
8. Ma W., Gramer M., Rossow K., and Yoon K.-J. Isolation and genetic characterization of new reassortant H3N1 swine influenza virus from pigs in the midwestern United States. J Virol 80 (2006) 5092-5096
9. Olsen C.W. The emergence of novel swine influenza viruses in North America. Virus Res 85 (2002) 199-210
10. Takano R., Nidom C.A., Kiso M., Muramoto Y., Yamada S., Shinya K., et al. A comparison of the pathogenicity of avian and swine H5N1 influenza viruses in Indonesia. Arch Virol 154 February (2009) 677-681
11. Myers K.P., Olsen C.W., and Gray G.C. Cases of swine influenza in humans: a review of the literature. CID 44 April (2007) 1084-1088
12. Vincent A., Swenson S., Lager K., Gauger P., Loiacono C., and Zhang Y. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet Micro 137 (2009) 51-59
13. Gray G.C., McCarthy T., Capuano A.W., Setterquist S.F., Olsen C.W., Alavanja M.C., et al. Swine workers and swine influenza virus infections. Emerg Infect Dis 13 December (2007) 1871-1878
14. Robinson J.L., Lee B.E., Patel J., Bastien N., Grimsrud K., Seal R.F., et al. Swine influenza (H3N2) infection in a child and possible community transmission, Canada. Emerg Infect Dis 13 December (2007) 1865-1870
15. Ginsberg M., Hopkins J., Maroufi A., Dunne G., Sunega D.R., Giessick J., et al. Swine influenza A (H1N1) infection in two children-southern california. Morb Mortal Wkly Rep 58 March-April (15) (2009) 400-3402
16. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Sciencexpress (2009) 10.1126/science.1176225
17. OIE 865 2009 [cited 2009, July 5]; Available from: URL: http://www.oie.int/wahis/reports/en_imm_0000008065_20090505_191855.pdf.
18. Project 2: Four Pig Pathogenesis Study with 2009 A/H1N1 Influenza A Virus. National Animal Disease Center 2009 [cited 2009, May 7]; Available from: URL: http://www.ars.usda.gov/2009H1N1/project2.pdf.
19. Kowalski J., Adkins K., Gangolli S., Ren J., Arendt H., DeStefano J., et al. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. Vaccine 25 (2007) 2296-2305
20. Kamrud K.I., Custer M., Dudek J.M., Owens G., Alterson K.D., Lee J.S., et al. Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 360 (2007) 376-387
21. Grieder F.B., Davis N.L., Aronson J.F., Charles P.C., Sellon D.C., Suzuki K., et al. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. J Virol 206 (1995) 994-1006
22. Kinney R.M., Change G.-J., Tsuchiya K.R., Sneider J.M., Roehrig J.T., Woodward T.M., et al. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′ -noncoding region and the E2 envelope glycoprotein. J Virol 67 (1993) 1269-1277
23. Hannoun C., Megas F., and Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 103 (2004) 133-138
24. Gray G.C., and Kayali G. Facing pandemic influenza threats: the importance of including poultry and swine workers in preparedness plans. Poult Sci 88 August (2008) 880-884